This is the FIRST live streamed only, three day professional conference on antibiotic resistance and alternatives. We have gathered together invited speakers from around the world, who you might not otherwise have access to.
Deadlines
Oral abstract submission deadline September 10th 2016
Early registration deadline September 20th 2016
Poster submissions deadline October 25th 2016
In the face of rising levels of antibiotic resistance, this live streamed international event will explore alternative strategies to infection control.
Meeting description: This event will discuss recent research into the development and spread of antibiotic resistance including its clinical impact, and a range of approaches to tackle this rise. Methods for infection control and monitoring of resistant strains, as well as novel therapeutic intervention strategies to reduce conventional antibiotic use will also be discussed.
We encourage questions, discussion and debate and have a relaxed atmosphere which generates maximum interaction online.
After registration you will be connected to an online networking site where you will be able to have discussions with all participants of this event, before, during and after the meeting.
Who Should Attend: Those with an interest in the rising levels of antibiotic resistance and in strategies aimed at overcoming drug resistance and/or developing new antimicrobial therapies would benefit from ths event. This includes academics, pharmacists, clinicians and pharmaceutical professionals.
The event will be recorded and available for all registered delegates up to a month after the event. So if you can’t manage all the days, or the different time zones, you can still have access to the full event.
Invited speakers and their talks Include
| Talk Title | Speaker | Affiliation | Country |
|---|---|---|---|
| Antivirulents instead of antibiotics | Dr Menachem Shoham | Cleveland, OH | United States |
| Disarming Pathogens: Benefits and Challenges of developing antimicrobials that target virulence instead of viability | Dr. Makrina Totsika | Queensland University of Technology | Australia |
| Novel enzyme-based antibacterials against Gram-negative pathogens that do not provoke resistance development | Dr Yves Briers | Gent | Belgium |
| Talk title to be confirmed | Dr Carolina Santillán Torres Torija | Universidad Nacional Autónoma de México | Mexico |
| High-Throughput Screening of Antibiotic-Resistant Bacteria in Picodroplets | Dr. Clive Smith | Sphere Fluidics Limited | United Kingdom |
| Complementary and Alternative Medicine as an alternative to antibiotics | Dr. Mubashir Arain | University of Calgary | Canada |
| New strategies for detection and control of antibiotic resistant bacteria | Dr. Iryna Sorokulova | Auburn University | United States |
| Extremely thermostable enzymes of bacteriophage origin - their use against Gram-negative bacteria | Dr Magdalena Plotka | University of Gdansk | Poland |
| Novel antivirulence agents against bacterial pathogens | Dr.Menachem Shoham | Case Western Reserve University | United States |
| Talk title to be confirmed | Dr Manuel Jose Vieira Simões | Faculdade de Engenharia da Universidade do Porto | Portugal |
| Beyond conventional antibiotitics | Dr. Deborah Hung | Harvard Medical School | United States |
| New perspectives to fight Burkholderia cenocepacia, a very dangerous Cystic Fibrosis pathogen | Dr Silvia Buroni | University of Pavia | Italy |
| Talk title to be confirmed | Professor Conrad Lichtenstein | Nemesis Bioscience Ltd | United Kingdom |
| Curcumin's derivatives as potential alternative agents to antibiotics on farm | Dr. Maria Grazia Cusimano | University of Palermo | Italy |
| Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates | Tania Raquel Martins dos Santos | Faculdade de Medicina Veterinária | Portugal |
| Bacteriophages as Natural, Self-Regulating and Self-Limiting Antimicrobials | Dr Elizabeth Martin Kutter | The Evergreen State College | United States |
| Quorum sensing inhibition to control bacterial disease: aquaculture as a case study | Professor Tom Defoirdt | Ghent University | Belgium |
| The viability of using bacteriophages to target infectious disease | Dr. Jim O'Mahony | Cork Institute of Technology | Ireland |
| Bacteriophage therapy- still promising, but not yet delivering | Dr. David R. Harper | Evolution Biotechnologies | United Kingdom |
| New molecules interfering with Staphylococcus aureus biofilm formation | Dr. Stella Maria Cascioferro | Università degli Studi di Palermo | Italy |
Developing antibiotics alternatives: A discussion of new approaches to overcoming antimicrobial resistance has an open abstract session:
Abstracts can be submitted on any subject related to antibiotics, antibiotic alternatives and antibiotic resistance
A Euroscicon live streamed event gives you access to a wider range of international speakers at a fraction of the cost of a real world event. Furthermore, you no longer have to worry about travel or accommodation expenses, or any arrangements you have which clash with our events.
Advisory Board Members
| Name | Affiliation | Country |
|---|---|---|
| Professor Robert Allaker | Barts and The London School of Medicine & Dentistry | United Kingdom |
| Dr Domenico Schillaci | Università degli Studi di Palermo | Italy |
| Dr Stephen Mortlock | Q2 Solutions | United States |
| Dr Ron Dixon | University of Lincoln | United Kingdom |
This is an International Life Science Community Internet event and has CPD accreditation
Related Past Event Agendas
